Resultado de búsqueda
Arvid Carlsson (Upsala, 25 de enero de 1923-Gotemburgo, 29 de junio de 2018) [1] fue un médico, neurocientífico, farmacólogo, farmacéutico y profesor universitario sueco. Se doctoró en medicina en la Universidad de Lund y desde 1959 hasta 1988 fue catedrático de farmacología de la Universidad de Gotemburgo , Suecia.
- Sueca
- 29 de junio de 2018 (95 años), Gotemburgo (Suecia)
- Gottfrid Carlsson
Arvid Carlsson (25 January 1923 – 29 June 2018) [2] [3] [4] was a Swedish neuropharmacologist who is best known for his work with the neurotransmitter dopamine and its effects in Parkinson's disease. For his work on dopamine, Carlsson was awarded the Nobel Prize in Physiology or Medicine in 2000, together with Eric Kandel and Paul Greengard.
25 de abr. de 2024 · Arvid Carlsson, Swedish pharmacologist who, along with Paul Greengard and Eric Kandel, was awarded the 2000 Nobel Prize for Physiology or Medicine for his research establishing dopamine as an important neurotransmitter in the brain. Carlsson’s work led to a treatment for Parkinson disease.
- The Editors of Encyclopaedia Britannica
Aquí nos gustaría mostrarte una descripción, pero el sitio web que estás mirando no lo permite.
26 de oct. de 2018 · 3 Altmetric. Metrics. On 29 June 2018, neuropsychopharmacology and the American College of Neuropsychopharmacology (ACNP) lost one of its giants and true pioneers, Dr. Arvid Carlsson, MD,...
- Birte Glenthøj, H. Christian Fibiger
- 2019
More than half a century ago, the Swedish scientist Arvid Carlsson performed basic research on the neurotransmitter dopamine that was rapidly translated into the first clinical treatment for Parkinson ’s disease. For his contributions, Carlsson shared the Nobel Prize in Physiology or Medicine in the year 2000.
On 29 June 2018, neuropsychopharmacology and the American College of Neuropsychopharmacology (ACNP) lost one of its giants and true pioneers, Dr. Arvid Carlsson, MD, PhD, Swedish pharmacologist...
